ALFA Finder| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 1.2 | -0.1 | 20.0 |
| Other income | 0.1 | 0.0 | 0.1 |
| Total income | 1.3 | -0.1 | 20.1 |
| Profit before exceptional items & tax | -3.0 | -3.5 | -2.0 |
| Exceptional items | -0.5 | -0.5 | -20.6 |
| Profit before tax | -3.5 | -4.0 | -22.5 |
| Net profit | -3.6 | -4.2 | -21.1 |
| Operating margin | -269.2% | n/m | -111.9% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | -94.00% |
|---|---|
| Operating profit, year on year | -47.60% |
| Operating profit, quarter on quarter | +11.40% |
BSE results filing, NSE: LASA. Figures extracted from the filing.
Lasa Supergenerics Ltd: key numbers
- Share price
- ₹4.22
- Market cap
- ₹21.14 Cr
- Revenue (annual)
- ₹25.14 Cr
- Net profit (annual)
- ₹-34.09 Cr
- P/E (TTM)
- -1.3×Sector 43.8×
- Promoter holding
- 53.65%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lasa Supergenerics Ltd
All →Lasa Supergenerics Board Meeting Date
Lasa Supergenerics scheduled its Board meeting for 14 Nov 2026 to approve Q1 and H1 FY27 results. No financial figures or decisions are disclosed yet.
Lasa Supergenerics Other Announcement
Lasa Supergenerics Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. This disclosure is a routine regulatory requirement.
Lasa Supergenerics Annual General Meeting
Lasa Supergenerics Limited held its 11th Annual General Meeting on September 30, 2026. Seven business items, including appointment of a director and borrowing powers, were discussed.
Lasa Supergenerics Annual Report
Lasa Supergenerics Ltd has submitted its 11th Annual Report for the financial year 2025-26. The Annual General Meeting is scheduled for September 30, 2026.
Lasa Supergenerics Annual General Meeting
Lasa Supergenerics Limited has issued a notice for its Annual General Meeting to be held on September 30, 2026, featuring seven agenda items.
Lasa Supergenerics Board Meeting Outcome
Lasa Supergenerics announced the outcome of its board meeting held on September 09, 2026. The board approved the notice for the 11th Annual General Meeting.